Multiphoton-excited intrinsic fluorescence emission signals from cells and tissues can be used for metabolic imaging and studies of disease morphology in chronic animal imaging experiments, and has diagnostic potential as a future in vivo clinical imaging tool. However, the signals are generally weak and require high laser intensities for imaging. Consequently, not only are viability studies important, but an investigation into the extent that multiphoton excitation is a mutagenic agent is critical. Information on the magnitude of permissible intensity levels of femtosecond pulsed near-IR light is vital to human clinical applications, yet there are currently no regulations that specifically indicate such parameters. This study is directed towards determining whether multiphoton imaging of cellular autofluorescence using 700 - 800 nm wavelength excitations causes mutations in mammalian cells. The induction of mutation by pulsed laser radiation employed for multiphoton imaging entails a risk of carcinogenicity in living tissue. The assessment of potential laser illumination toxicity was carried out by the hypoxanthine-guanine phosphoribosyl (HPRT) mammalian cell gene mutation assay, which measures mutation at the HPRT gene locus in cells, and is one of a handful of reporter loci that have been used as molecular biomarkers for both human and rodent exposure to mutagens and UV light. Experiments were performed to assess possible mutagenic effects of various intensities of 755 nm, 100 fs laser irradiation. Laser powers ranging from 20 to as high as 100 mW delivered as raster scanned excitation through a 0.7 NA objective for 20 seconds was found to be nonmutagenic to the HPRT gene locus test system, while higher laser powers initiated mutagenic responses.